{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.332","meta":{"versionId":"9","lastUpdated":"2021-03-06T01:00:21.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.332","version":"20210306","name":"Daunorubicin Injectable","status":"active","date":"2021-03-06T01:00:21-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"2002002","display":"10 ML daunorubicin 5 MG/ML Injection"},{"code":"309650","display":"4 ML daunorubicin 5 MG/ML Injection"},{"code":"646830","display":"25 ML daunorubicin liposomal 2 MG/ML Injection"}]}]},"expansion":{"identifier":"urn:uuid:0c29ee1d-f98d-41ed-a51c-aba7bdea297e","timestamp":"2022-06-10T06:48:11-04:00","total":2,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"2002002","display":"10 ML daunorubicin 5 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"309650","display":"4 ML daunorubicin 5 MG/ML Injection"}]}}